# Relaxo Footwears share price today (Relaxo Footwears Ltd, NSE: RELAXO) > Relaxo Footwears share price today: ₹283.85 at the NSE close on 3 November 2026, down 34.9% in a year. Relaxo Footwears (NSE: RELAXO) is worth ₹7,080 crore, trades at a P/E of 38.2 and has closed between ₹249.75 and ₹439.95 over the past 52 weeks. > Relaxo Footwears Ltd's earnings have grown faster than its share price. Earnings per share grew +5.3% in a year while the price moved −34.9%. RELAXO · Footwear · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/relaxo-footwears-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Business trend: Getting better, from the last 12 quarters - Price: ₹283.85 (−34.9% in a year) - P/E: 38.2× (lower than 99% of the last 11 years) - Revenue (Jun 2026): ₹705 Cr (+7.8% on a year ago) - Profit (Jun 2026): ₹55.0 Cr (+12.2% on a year ago) - Operating margin: 15.0% (flat on a year ago) - ROCE: 11%, FY26 - ROIC: 7.5%, against a 12.0% cost of capital: −4.5 points The main question: yearly earnings per share moved +5.3% while the share price moved −34.9%. ## What is the Relaxo Footwears share price today? Relaxo Footwears Ltd's share price was ₹283.85 at the close on 3 November 2026. It has been falling for 6 weeks. That is 19.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹250 and ₹440, and at that close it sat 18% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 11 weeks running. Over the last 11 years the share price moved +47% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 21 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Relaxo Footwears this quarter? One change stood out: indian funds and insurers (DIIs) cut their stake for 6 quarters in a row. 1. Indian funds and insurers (DIIs) cut their stake for 6 quarters in a row From 10.6% to 9.6% of the company by the September 2026 quarter. ## What are Relaxo Footwears' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Relaxo Footwears reported revenue of ₹705 crore, up 7.8% from ₹654 crore a year earlier, and a profit of ₹55.0 crore, up 12.2% from ₹49.0 crore. ### Relaxo Footwears results: April to June 2026 against a year earlier | Measure | April to June 2026 | April to June 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹705 crore | ₹654 crore | +7.8% | | Profit | ₹55.0 crore | ₹49.0 crore | +12.2% | | Earnings per share | ₹2.21 | ₹1.96 | +12.8% | | Operating margin | 15.0% | 15.0% | 0.0 points | The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 29 May 2026, about January to March 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.) ## What is the Relaxo Footwears share price history? Relaxo Footwears closed at ₹283.85 on 3 November 2026, down 34.9% from ₹436.15 a year earlier (31 October 2025) and down 80.2% over five years. Its highest weekly close since March 2016 was ₹1,436.20 on 4 November 2021. ### Relaxo Footwears share price: then and now | When | Close | Change to 3 Nov 2026 | | --- | --- | --- | | 1 week ago · 23 Oct 2026 | ₹279.20 | +1.7% | | 1 month ago · 1 Oct 2026 | ₹285.35 | −0.5% | | 6 months ago · 30 Apr 2026 | ₹298.09 | −4.8% | | 1 year ago · 31 Oct 2025 | ₹436.15 | −34.9% | | 3 years ago · 3 Nov 2023 | ₹907.40 | −68.7% | | 5 years ago · 4 Nov 2021 | ₹1,436.20 | −80.2% | | 10 years ago · 4 Nov 2016 | ₹205.18 | +38.3% | | Earliest weekly close in our records · 11 Mar 2016 | ₹193.28 | +46.9% | | Highest weekly close since March 2016 · 4 Nov 2021 | ₹1,436.20 | −80.2% | | Lowest weekly close since March 2016 · 23 Mar 2016 | ₹186.08 | +52.5% | | 52-week high (weekly close) · 17 Jul 2026 | ₹439.95 | −35.5% | | 52-week low (weekly close) · 27 Mar 2026 | ₹249.75 | +13.7% | Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (563 weekly closes from 11 March 2016 to 3 November 2026.) ## What is the latest news on Relaxo Footwears? 3 Nov 2026: Relaxo Footwears closed at ₹283.85, up 1.7% on the week and down 0.5% on the month. 18 Sep 2026: ex-date for a dividend of ₹3.50 a share. ### Earlier - Results for April to June 2026: Revenue up 7.8% and profit up 12.2% on a year earlier. - 29 May 2026: Relaxo Footwears held its results call for January to March 2026. Management guided: FY27 operating margin goal 14.8% (100 basis points improvement from FY26 base of 13.8%) ## What dividend does Relaxo Footwears pay? Relaxo Footwears paid ₹3.50 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 1.23% at the ₹283.85 close on 3 November 2026. The last was a dividend of ₹3.50 a share, ex-date 18 September 2026. ### Relaxo Footwears dividends since 1 April 2021 | Ex-date | Dividend per share | Type | Record date | | --- | --- | --- | --- | | 18 Sep 2026 | ₹3.50 | Dividend | same day | | 21 Aug 2025 | ₹3 | Dividend | same day | | 22 Aug 2024 | ₹3 | Dividend | same day | | 17 Aug 2023 | ₹2.50 | Dividend | n/a | | 17 Aug 2022 | ₹2.50 | Dividend | 18 Aug 2022 | | 17 Aug 2021 | ₹2.50 | Dividend | 19 Aug 2021 | Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record Yes. Relaxo Footwears Ltd paid out 49% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.) ## What did Relaxo Footwears management say on the latest results call? On the call for January to March 2026, held on 29 May 2026, Relaxo Footwears' management guided: FY27 operating margin goal 14.8% (100 basis points improvement from FY26 base of 13.8%) > “We intend to do better than last year's overall operating margin of 13.8%. We are aiming for an improvement of perhaps 1% plus.” > Management, on the call for January to March 2026 ### What management guided - FY27 volume growth goal 4.0%-5.0% per annum. - FY27 capital spending ₹180-200 crore total (versus ₹130 crore in FY26) - EBO expansion: 100 new stores planned in FY27, phased 30.0%-40.0% (30-40 units) in H1 with remainder by year-end; store format profitability already demonstrated through trials. - Advertising spend maintenance: continue 4.0%-5.0% of sales ratio for FY27, strategic shift allocation toward digital channels from television. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/3304-29-May-2026.pdf). (From the call for January to March 2026, 29 May 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.) ## What to watch in Relaxo Footwears' next results? When Relaxo Footwears reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Price hike volume elasticity in general trade channel - management implemented 15.0%-18.0% price increases Q4 onwards but full consumer demand impact not yet visible as pricing graduated through May; general trade showing recovery but underlying organic growth only 5.0%-6.0% suggests price resistance building. - What to check (from the call) - Price hike volume elasticity in general trade channel - management implemented 15.0%-18.0% price increases Q4 onwards but full consumer demand impact not yet visible as pricing graduated through May; general trade showing recovery but underlying organic growth only 5.0%-6.0% suggests price resistance building. - EBO expansion execution pace and unit economics validation - 100 store goal requires 30.0%-40.0% (30-40 units) openings in H1 FY27; capital spending guidance and margin accretion assumptions directly depend on stage-gate proof of concept and per-store profitability replication. - Raw material cost trajectory stabilization versus wage permanence - raw materials settling downward but 25.0%-30.0% Haryana wage inflation confirmed structural; next quarter will signal whether materials stabilize fully and whether management needs incremental price actions if wage pressures broaden to other states. - Premium product mix uptake at ₹2,500 price point - Sparx range expansion to ₹2,800 launched in Q4/Q1 but no sales penetration data yet available; ASP improvement and margin expansion trajectories both hinge on premiumization acceptance across EBO and e-commerce channels. ## Which stock lists is Relaxo Footwears on? Relaxo Footwears is not on any of our India lists this week. ## Is Relaxo Footwears profitable? Relaxo Footwears Ltd earned ₹55.0 Cr of net profit in the Jun 2026 quarter, +12.2% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹179 Cr. Over 10 years profit has grown 4.1% a year on average. That is 7.8% of the quarter's revenue. The same quarter a year earlier earned ₹49.0 Cr. For the full year, FY26 profit was ₹179 Cr (+5.3% on the year before). Why profit moved: revenue changed +7.8% on a year earlier and the margin moved +0.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +3.2% and revenue +2.1%. Profit and revenue are moving at about the same pace. ## How much revenue does Relaxo Footwears make, and is it growing? Relaxo Footwears Ltd reported ₹705 Cr of revenue in the Jun 2026 quarter, +7.8% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 10 years it has grown 4.9% a year on average. The last full year, FY26, came in at ₹2,702 Cr. The last four reported quarters add to ₹2,753 Cr. FY26 revenue was ₹2,702 Cr, −3.2% on the year before. Recent pace: the last four quarters grew +2.1% on average, against 4.9% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +2.2%, against −3.0% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +6.3%, against −0.5% a year (accelerating). ## How much of every ₹100 of sales does Relaxo Footwears keep? Relaxo Footwears Ltd's operating margin was 15.0% in the Jun 2026 quarter, about the same as the same quarter a year ago. Across 13 years it has been between 12.0% and 21.0%. The latest quarter is within that range. In the latest quarter it moved +0.0 percentage points on the same quarter a year ago. Why the margin moved: operating margin changed +0.2 percentage points on the year while gross margin changed +4.8 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Relaxo Footwears' profit turning into cash? Over the last 3 years, 180% of Relaxo Footwears Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹348 Cr of operating cash against ₹179 Cr of profit. After ₹221 Cr of spending on assets, ₹127 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 180% of profit came in as cash: the cash cycle got 37 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Relaxo Footwears' cash go? Relaxo Footwears Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 138 days in FY26, up from 101 days in FY21. It spent ₹685 Cr on assets over the last 3 years. Customers take 40 days to pay, and stock sits for 184 days on average. At FY26 sales of ₹2,702 Cr, each day of that cycle ties up about ₹7.4 Cr, so roughly ₹1,022 Cr is tied up in the business at any time. FY26: customers took 40 days to pay and stock sat for 184 days, about 6.1 months of sales sitting as stock, for a full cycle of 138 days, longer than FY21's 101. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 184 days. Customers pay about 40 days after that. Suppliers are paid at 87 days. Together that makes the 138-day cycle. Spending on assets: ₹685 Cr over the last 3 years, against ₹462 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹97.0 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Relaxo Footwears' P/E ratio, and how does it compare with its own history? Relaxo Footwears Ltd's P/E is 38.2×, about the lowest it has ever been. Its usual P/E (the middle reading) is 67.0×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +5.3% while the price moved −34.9%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −27.7% a year; about −9.1% a year came from earnings growth and about −18.6 percentage points from the multiple (the market paying less); over 10 years the price moved +3.3% a year; about +4.0% a year came from earnings growth and about −0.7 percentage points from the multiple (roughly no change). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Relaxo Footwears business getting better or worse? Relaxo Footwears Ltd's business is getting better. Profit growth hit its low 5 quarters ago at −13.4% and has recovered to +6.3%, with ROCE steady at 11.5%. This is based on 12 quarters of 4 measures. Why it matters: a lasting rise from a low is what this page is built to show. ## How much does Relaxo Footwears earn on its capital? Relaxo Footwears Ltd earned a ROCE of 11% in FY26. Its return on capital used (ROIC) is 4.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 6.6% net margin and 0.92× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 6.6% net margin × 0.92× asset turnover × 1.34× leverage (assets divided by equity) ≈ 8.1% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 7.5% − 12.0% = −4.5 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Relaxo Footwears have too much debt? Relaxo Footwears Ltd has total debt of ₹233 Cr against shareholder equity of ₹2,206 Cr as of Jun 2026, so its debt is 0.11× its equity, which is very little. Year by year, that ratio went from 0.10 in FY22 to 0.11 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Relaxo Footwears shareholding pattern? No group of Relaxo Footwears Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved −0.4 points over the same period, to 9.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −0.4 points over 8 quarters, to 3.0%; Domestic institutions: −0.4 points over 8 quarters, to 9.6%; Promoters: +0.0 points over 8 quarters, to 71.3%. ## How far is Relaxo Footwears from balance-sheet trouble? For Relaxo Footwears Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Relaxo Footwears rank in its industry? 35.5 out of 100, rank 6 of 7 in Footwear, with 86% of the evidence available. Relaxo Footwears Ltd scores 35.5 out of 100 against the 7 companies it is compared with in Footwear, ranking 6. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 12.7 + 11.8 + 11 + 0 = 35.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Relaxo Footwears compared with? Relaxo Footwears ranks 6 of 7 Footwear companies on the 4-Factor Sector Score, with 35.5 out of 100. 1. [Redtape Ltd](https://www.sectoralpha.in/stocks/redtape-ltd) REDTAPE · quiet · Most evidence points up · 96% evidence 66.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.8/35 · Revenue 19% · Profit 38.8% · Operating margin change 0 points · 88% evidence Capital efficiency 19.1/25 · ROCE 24.5% · Operating margin 17% · 100% evidence Valuation 18.4/20 · P/E 23.2× · PEG 0.76 · 100% evidence Relative strength 2.6/20 · Lead over its industry -6.4% · Lead over NIFTY 500 -12.9% · 1 year -24.6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 26.8 + 19.1 + 18.4 + 2.6 = 66.9 · What this means: Earnings are strong; relative strength in its sector is -6.4% and the one-year return is -24.6%. 2. [Sreeleathers Ltd](https://www.sectoralpha.in/stocks/sreeleathers-ltd) SREEL · breaking out · Evidence leans up · 81% evidence 64.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.4/35 · Revenue 16.7% · Profit 56.9% · Operating margin change 7 points · 88% evidence Capital efficiency 9.1/25 · ROCE 7% · Operating margin 14.9% · 100% evidence Valuation 14.5/20 · P/E 17.8× · PEG 0.81 · 100% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 20% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 28.4 + 9.1 + 14.5 + 12.5 = 64.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Metro Brands Ltd](https://www.sectoralpha.in/stocks/metro-brands-ltd) METROBRAND · basing · Evidence leans up · 85% evidence 56.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 15.6% · Profit 17.3% · Operating margin change 1 points · 100% evidence Capital efficiency 20.6/25 · ROCE 20.1% · Operating margin 27% · 100% evidence Valuation 6.1/20 · P/E 54.1× · PEG 4.34 · 100% evidence Relative strength 8.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -14.7% · 1 year -27.1% · 25% evidence · 0 of 12 weeks ahead Exact sum: 20.7 + 20.6 + 6.1 + 8.8 = 56.2 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 4. [Campus Activewear Ltd](https://www.sectoralpha.in/stocks/campus-activewear-ltd) CAMPUS · quiet · Evidence leans up · 81% evidence 55.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 13.8% · Profit 31.6% · Operating margin change 0 points · 88% evidence Capital efficiency 16.3/25 · ROCE 21.2% · Operating margin 14% · 100% evidence Valuation 10.7/20 · P/E 37.9× · PEG 2.04 · 100% evidence Relative strength 8.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -16.3% · 1 year -31.8% · 25% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 16.3 + 10.7 + 8.2 = 55.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Bata India Ltd](https://www.sectoralpha.in/stocks/bata-india-ltd) BATAINDIA · basing · Evidence leans down · 71% evidence 39.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 8.5/35 · Revenue 1.9% · Profit -30.1% · Operating margin change 0 points · 88% evidence Capital efficiency 13.2/25 · ROCE 12.7% · Operating margin 21% · 100% evidence Valuation 8.5/20 · P/E 46.5× · PEG n/a · 50% evidence Relative strength 9.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -13.3% · 1 year -41.3% · 25% evidence · 0 of 12 weeks ahead Exact sum: 8.5 + 13.2 + 8.5 + 9.5 = 39.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. Relaxo Footwears Ltd this page RELAXO · quiet · Evidence leans down · 86% evidence 35.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.7/35 · Revenue 2.1% · Profit 6.3% · Operating margin change 0 points · 88% evidence Capital efficiency 11.8/25 · ROCE 11.2% · Operating margin 15% · 100% evidence Valuation 11.0/20 · P/E 36.6× · PEG n/a · 50% evidence Relative strength 0.0/20 · Lead over its industry -11.6% · Lead over NIFTY 500 -18.1% · 1 year -37.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 12.7 + 11.8 + 11 + 0 = 35.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Mirza International Ltd](https://www.sectoralpha.in/stocks/mirza-international-ltd) MIRZAINT · Too little evidence to rank firmly · 56% evidence 26.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.1/43.75 · Revenue -9.3% · Profit 100% · Operating margin change -6.7 points · 88% evidence Capital efficiency 0.8/31.25 · ROCE -1.8% · Operating margin 2.4% · 100% evidence Valuation 12.5/25 · P/E n/a · PEG n/a · 0% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 13.1 + 0.8 + 12.5 = 26.4 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Footwear](https://www.sectoralpha.in/sectors/footwear), all 7 compared on one page. ## Which companies are close to Relaxo Footwears in size? Relaxo Footwears is the 3rd largest of 7 Footwear companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Metro Brands and Bata India. Just below it: Campus Activewear, Redtape, Sreeleathers and Mirza International. ### Footwear companies close in size 1. [Metro Brands Ltd](https://www.sectoralpha.in/stocks/metro-brands-ltd) ₹22,443 crore 2. [Bata India Ltd](https://www.sectoralpha.in/stocks/bata-india-ltd) ₹8,076 crore 3. Relaxo Footwears Ltd ₹6,784 crore 4. [Campus Activewear Ltd](https://www.sectoralpha.in/stocks/campus-activewear-ltd) ₹5,834 crore 5. [Redtape Ltd](https://www.sectoralpha.in/stocks/redtape-ltd) ₹5,724 crore 6. [Sreeleathers Ltd](https://www.sectoralpha.in/stocks/sreeleathers-ltd) ₹586 crore 7. [Mirza International Ltd](https://www.sectoralpha.in/stocks/mirza-international-ltd) ₹459 crore [All 7 Footwear companies, largest first](https://www.sectoralpha.in/sectors/footwear#all-companies) ### Companies close in size in other industries 1. [Supriya Lifescience Ltd](https://www.sectoralpha.in/stocks/supriya-lifescience-ltd) ₹6,819 crore · Pharma - API & CRAMS 2. [Ceigall India Ltd](https://www.sectoralpha.in/stocks/ceigall-india-ltd) ₹6,797 crore · Construction - Civil/Turnkey 3. Relaxo Footwears Ltd ₹6,784 crore 4. [NDR INVIT Trust](https://www.sectoralpha.in/stocks/ndr-invit-trust) ₹6,779 crore · Infrastructure Investment Trusts 5. [ISGEC Heavy Engineering Ltd](https://www.sectoralpha.in/stocks/isgec-heavy-engineering-ltd) ₹6,762 crore · Infra - Engineering - General ## What else do people ask about Relaxo Footwears? ### What is Relaxo Footwears's share price today? Relaxo Footwears Ltd's share price is ₹283.85, −34.9% over the past year. The whole company is worth ₹7,080 Cr on the market. In the last 52 weeks it traded between ₹250 to ₹440; today it is 18% of the way up from the low, 19.5% below its 200-day average (as of 3 November 2026). ### What were Relaxo Footwears's latest quarterly results? Relaxo Footwears Ltd reported revenue of ₹705 Cr and net profit of ₹55.0 Cr for the Jun 2026 quarter. Revenue rose 7.8% and profit rose 12.2% compared with a year earlier. Earnings per share were ₹2.21. The operating margin was 15.0%, 0.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Relaxo Footwears's market cap? Relaxo Footwears Ltd's market capitalisation is ₹7,080 Cr at a share price of ₹283.85. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Relaxo Footwears performing? Relaxo Footwears Ltd's share price has been falling for 6 weeks. In its latest quarter, revenue rose 7.8% and profit rose 12.2% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 11 weeks running (as of 3 November 2026). ### Will Relaxo Footwears's share price go up? This page does not forecast Relaxo Footwears Ltd's share price. What it shows instead: the share price is ₹283.85, and it has been falling for 6 weeks. Its P/E of 38.2× is higher than 1% of its own last 11 years (as of 3 November 2026). ### Who owns Relaxo Footwears? Promoters own 71.3% of Relaxo Footwears Ltd, foreign institutions 3.0%, domestic institutions 9.6% and the public 16.2% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Where is Relaxo Footwears in its business cycle? Relaxo Footwears Ltd's FY26 operating margin was 14.0%, against a 13-year range of 12.0% to 21.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 15.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Relaxo Footwears story? The main question: yearly earnings per share moved +5.3% while the share price moved −34.9%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Relaxo Footwears a stock worth studying right now? What the numbers show: Relaxo Footwears Ltd's earnings have grown faster than its share price. Earnings per share grew +5.3% in a year while the price moved −34.9%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Relaxo Footwears share price forecast for 2026? What management itself guided: FY27 operating margin goal 14.8% (100 basis points improvement from FY26 base of 13.8%) This is research, not advice. We’re not SEBI-registered.